FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Lunt

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

Co-author Network

Publications

TOP 3
S A Owen; Wendy Thomson; John Bowes; Ian Bruce; Samantha L Hider; Mark Lunt; Anne Barton
MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.
Bo Fu; James Galloway; Kimme Hyrich; Mark Lunt; Will Dixon; Deborah Symmons
A threshold hazard model for estimating serious infection risk following anti-tumor necrosis factor therapy in rheumatoid arthritis patients.
Rebecca Davies; WG Dixon; Kimme L Hyrich; Mark Lunt; Deborah P M Symmons; Kath D Watson
Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Lunt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S A Owen; Wendy Thomson; John Bowes; Ian Bruce; Samantha L Hider; Mark Lunt; Anne Barton
MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.
The pharmacogenomics journal 2013;13(2):137-47.
2013: Bo Fu; James Galloway; Kimme Hyrich; Mark Lunt; Will Dixon; Deborah Symmons
A threshold hazard model for estimating serious infection risk following anti-tumor necrosis factor therapy in rheumatoid arthritis patients.
Journal of biopharmaceutical statistics 2013;23(2):461-76.
2013: Rebecca Davies; WG Dixon; Kimme L Hyrich; Mark Lunt; Deborah P M Symmons; Kath D Watson
Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK.
Annals of the rheumatic diseases 2013;72(3):461-2.
2013: Sebastien Viatte; Jane Worthington; Adam Young; Josh J Dixey; Edward Flynn; Bo Fu; James Galloway; Mark Lunt; Ben J Parker; Darren Plant; Csilla Solymossy; Deborah P M Symmons; Anne Barton
Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage.
The Journal of rheumatology 2013;40(2):144-56.
2013: James B Galloway; Matthew Helbert; Kimme L Hyrich; Mark Lunt; Louise K Mercer; Alison Moseley; Andrew P Ustianowski; Kath D Watson; WG Dixon; Deborah Pm Symmons
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases 2013;72(2):229-34.
2013: Louise K Mercer; Deborah P M Symmons; Kath D Watson; Rebecca Davies; WG Dixon; James B Galloway; Kimme L Hyrich; Audrey Low; Mark Lunt
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.
Rheumatology (Oxford, England) 2013;52(1):91-8.
2013: J H Humphreys; Mark Lunt; H Mirjafari; Ian N Bruce; Diane Bunn; S M M Verstappen; D P M Symmons
Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Arthritis care & research 2013;65(1):122-6.
2012: Sebastien Viatte; Anne Barton; John Bowes; Stephen Eyre; Mark Lunt; Darren Plant; Jane Worthington
Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients.
Annals of the rheumatic diseases 2012;71(12):1984-90.
2012: Moetaza M Soliman; Deborah P M Symmons; Kath D Watson; Darren M Ashcroft; Kimme L Hyrich; Mark Lunt
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.
Arthritis care & research 2012;64(8):1108-15.
2012: Louise K Mercer; Deborah P M Symmons; Kath D Watson; Rebecca Davies; WG Dixon; James B Galloway; Adele C Green; Kimme L Hyrich; Mark Lunt
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases 2012;71(6):869-74.
2012: E M Camacho; Mark Lunt; Diane Bunn; S M M Verstappen; Deborah Symmons
Multiple adverse pregnancy outcomes before symptom onset are associated with a worse disease outcome in women with recent-onset inflammatory polyarthritis.
Annals of the rheumatic diseases 2012;71(4):528-33.
2012: Moetaza M Soliman; Deborah P M Symmons; Kath D Watson; Darren M Ashcroft; Kimme L Hyrich; Mark Lunt
Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register.
The Journal of rheumatology 2012;39(2):240-6.
2011: Elizabeth M Camacho; Mark Lunt; Diane Bunn; Suzanne M M Verstappen; Deborah P M Symmons
Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Arthritis care & research 2011;63(12):1745-52.
2011: J B Galloway; M Helbert; Kimme L Hyrich; Mark Lunt; L K Mercer; D P M Symmons; Andrew P Ustianowski; Kath D Watson; WG Dixon
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases 2011;70(10):1810-4.
2011: Rebecca Davies; James B Galloway; Kimme L Hyrich; Mark Lunt; Deborah P M Symmons; Kath D Watson
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases 2011;70(10):1831-4.
2011: Suzanne M M Verstappen; Diane Bunn; Mark Lunt; D G I Scott; Deborah Symmons
In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register.
Annals of the rheumatic diseases 2011;70(8):1428-32.
2011: Carlo A Scirè; Suzanne M M Verstappen; Ian N Bruce; Diane Bunn; Mark Lunt; Hoda Mirjafari; Carlomaurizio Montecucco; Deborah Symmons
Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register.
Arthritis care & research 2011;63(7):945-52.
2011: Moetaza M Soliman; Darren M Ashcroft; Kath D Watson; Mark Lunt; Deborah P M Symmons; Kimme L Hyrich
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases 2011;70(4):583-9.
2011: Hoda Mirjafari; Deborah P M Symmons; Suzanne M M Verstappen; Allen Yates; Diane Bunn; Tracey Farragher; Mark Lunt; Tarnya Marshall; Ian N Bruce
Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.
Arthritis research & therapy 2011;13(5):R159.
2011: James B Galloway; Kimme L Hyrich; Louise K Mercer; WG Dixon; Bo Fu; Andrew P Ustianowski; Kath D Watson; Mark Lunt; Deborah P M Symmons
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.
Rheumatology (Oxford, England) 2011;50(1):124-31.
2011: Kimme L Hyrich; Kath D Watson; Mark Lunt; Deborah P M Symmons
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.
Rheumatology (Oxford, England) 2011;50(1):117-23.
2011: Darren Plant; Wendy Thomson; Mark Lunt; Edward Flynn; Paul Martin; Stephen Eyre; Tracey Farragher; Diane Bunn; Jane Worthington; Deborah Symmons; Anne Barton
The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Rheumatology (Oxford, England) 2011;50(1):78-84.
2010: S A Owen; Mark Lunt; Samantha L Hider; Ian Bruce; Anne Barton; Wendy Thomson
Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.
Arthritis and rheumatism 2010;62(12):3827-9.
2010: Mark Lunt; Kath D Watson; WG Dixon; Deborah P M Symmons; Kimme L Hyrich
No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Arthritis and rheumatism 2010;62(11):3145-53.
2010: E M Camacho; Tracey Farragher; Mark Lunt; S M M Verstappen; Diane Bunn; Deborah Symmons
The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Annals of the rheumatic diseases 2010;69(10):1834-7.
2010: Jarrod Franklin; Tracey Farragher; Mark Lunt; Elizabeth M Camacho; Diane Bunn; Tarnya Marshall; Deborah Symmons
Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis.
Annals of the rheumatic diseases 2010;69(9):1660-4.
2010: Suzanne M M Verstappen; Kath D Watson; Mark Lunt; Katie McGrother; Deborah P M Symmons; Kimme L Hyrich
Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford, England) 2010;49(8):1570-7.
2010: Ariane L Herrick; Mark Lunt; Alan J Silman; Christopher P Denton
Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.
Rheumatology (Oxford, England) 2010;49(8):1607-8; author reply 1608.
2010: WG Dixon; Kath D Watson; Mark Lunt; L K Mercer; Kimme L Hyrich; D P M Symmons
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
Arthritis care & research 2010;62(6):755-63.
2010: WG Dixon; Kimme L Hyrich; Kath D Watson; Mark Lunt; Deborah Symmons
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.
Annals of the rheumatic diseases 2010;69(6):1086-91.
2010: Tracey Farragher; Mark Lunt; Darren Plant; Diane Bunn; Anne Barton; Deborah P M Symmons
Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.
Arthritis care & research 2010;62(5):664-75.
2010: Tracey Farragher; Mark Lunt; Bo Fu; Diane Bunn; Deborah P M Symmons
Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.
Annals of the rheumatic diseases 2010;69(4):689-95.
2010: Paul A C Lord; Tracey M Farragher; Mark Lunt; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford, England) 2010;49(3):563-70.
2010: WG Dixon; Kimme L Hyrich; Kath D Watson; Mark Lunt; J Galloway; A Ustianowski; D P M Symmons
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).
Annals of the rheumatic diseases 2010;69(3):522-8.
2010: Mark J Harrison; Mark Lunt; Suzanne M M Verstappen; Kath D Watson; Nick J Bansback; Deborah P M Symmons
Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
Health and quality of life outcomes 2010;8():21.
2010: Ariane L Herrick; Mark Lunt; Nina Whidby; Holly Ennis; Alan Silman; Neil McHugh; Christopher P Denton
Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis.
The Journal of rheumatology 2010;37(1):116-24.
2009: Annie McClure; Mark Lunt; Stephen Eyre; Xiayi Ke; Wendy Thomson; Anne Hinks; John Bowes; Laura Gibbons; Darren Plant; Anthony G Wilson; Ioanna Marinou; Ann W Morgan; Paul Emery; Sophia Steer; Lynne J Hocking; David M Reid; Paul Wordsworth; Pille Harrison; Jane Worthington; Anne Barton
Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci.
Rheumatology (Oxford, England) 2009;48(11):1369-74.
2009: Kimme L Hyrich; Chris Deighton; Kath D Watson; Deborah Symmons; Mark Lunt
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.
Rheumatology (Oxford, England) 2009;48(10):1323-7.
2009: Mark Lunt; Daniel Solomon; Kenneth Rothman; Robert Glynn; Kimme Hyrich; Deborah Symmons; Til Stuermer
Different methods of balancing covariates leading to different effect estimates in the presence of effect modification.
American journal of epidemiology 2009;169(7):909-17.
2008: Kimme L Hyrich; Mark Lunt; WG Dixon; Kath D Watson; Deborah Symmons
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.
Rheumatology (Oxford, England) 2008;47(7):1000-5.
2008: Judith Thornton; Mark Lunt; Darren M Ashcroft; Eileen Baildam; H Foster; Joyce Davidson; J Gardner-Medwin; M W Beresford; Deborah Symmons; Wendy Thomson; Rachel Elliott
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis.
Rheumatology (Oxford, England) 2008;47(7):985-90.
2008: N Adib; Kimme L Hyrich; Judith Thornton; Mark Lunt; Joyce Davidson; J Gardner-Medwin; H Foster; Eileen Baildam; L Wedderburn; Wendy Thomson
Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study.
Rheumatology (Oxford, England) 2008;47(7):991-5.
2008: Vishal R Aggarwal; John McBeth; Joanna zakrzewska; Mark Lunt; Gary Macfarlane
Are reports of mechanical dysfunction in chronic oro-facial pain related to somatisation? A population based study.
European journal of pain (London, England) 2008;12(4):501-7.
2007: Lorna J Kennedy; Mark Lunt; Annette Barnes; Lorraine McElhinney; Anthony R Fooks; David N Baxter; W E R Ollier
Factors influencing the antibody response of dogs vaccinated against rabies.
Vaccine 2007;25(51):8500-7.
2007: C Morgan; Mark Lunt; Diane Bunn; D G I Scott; Deborah Symmons
Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
Rheumatology (Oxford, England) 2007;46(12):1819-23.
2007: Marina Vivarelli; Leila E D'Urbano; Antonella Insalaco; Mark Lunt; Francine Jury; Alberto Tozzi; Angelo Ravelli; Alberto Martini; Rachelle Donn; de benedetti fabrizio
Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
Clinical and experimental rheumatology 2007;25(5):775-81.
2007: WG Dixon; Deborah Symmons; Mark Lunt; Kath D Watson; Kimme L Hyrich; Alan J Silman
Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.
Arthritis and rheumatism 2007;56(9):2896-904.
2007: WG Dixon; Kath D Watson; Mark Lunt; Kimme L Hyrich; Alan J Silman; Deborah Symmons
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
Arthritis and rheumatism 2007;56(9):2905-12.
2007: B Palmer; Gary Macfarlane; Cara Afzal; Aneez Esmail; Alan Silman; Mark Lunt
Acculturation and the prevalence of pain amongst South Asian minority ethnic groups in the UK.
Rheumatology (Oxford, England) 2007;46(6):1009-14.
2007: Yasmeen Ahmad; J Shelmerdine; Helena Bodill; Mark Lunt; M G Pattrick; Lee-Suan Teh; Robert M Bernstein; Michael G Walker; Ian N Bruce
Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
Rheumatology (Oxford, England) 2007;46(6):983-8.
2007: Tracey Farragher; Mark Lunt; Diane Bunn; Alan J Silman; Deborah Symmons
Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Annals of the rheumatic diseases 2007;66(4):486-92.
2007: Jarrod Franklin; Mark Lunt; Diane Bunn; Deborah Symmons; Alan Silman
Influence of inflammatory polyarthritis on cancer incidence and survival: results from a community-based prospective study.
Arthritis and rheumatism 2007;56(3):790-8.
2007: Gary Macfarlane; Mark Lunt; Benedict Palmer; Cara Afzal; Alan J Silman; Aneez Esmail
Determining aspects of ethnicity amongst persons of South Asian origin: the use of a surname-classification programme (Nam Pehchan).
Public health 2007;121(3):231-6.
2007: Stephen R Pye; David M Reid; Mark Lunt; Judith E Adams; Alan J Silman; Terence W O'Neill
Lumbar disc degeneration: association between osteophytes, end-plate sclerosis and disc space narrowing.
Annals of the rheumatic diseases 2007;66(3):330-3.
2007: Jarrod Franklin; Mark Lunt; Diane Bunn; Deborah Symmons; Alan Silman
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis.
Annals of the rheumatic diseases 2007;66(3):308-12.
2007: Marwan Bukhari; Mark Lunt; Anne Barton; Diane Bunn; Alan Silman; Deborah Symmons
Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis.
Annals of the rheumatic diseases 2007;66(3):389-93.
2007: Vishal R Aggarwal; John McBeth; Mark Lunt; Joanna zakrzewska; Gary Macfarlane
Development and validation of classification criteria for idiopathic orofacial pain for use in population-based studies.
Journal of orofacial pain 2007;21(3):203-15.
2007: Kimme L Hyrich; Mark Lunt; Kath D Watson; Deborah Symmons; Alan J Silman
Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.
Arthritis and rheumatism 2007;56(1):13-20.
2006: Samantha L Hider; Alan Silman; Diane Bunn; S Manning; Deborah Symmons; Mark Lunt
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis.
Annals of the rheumatic diseases 2006;65(11):1449-55.
2006: WG Dixon; K Watson; Mark Lunt; Kimme L Hyrich; Alan J Silman; Deborah Symmons
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Arthritis and rheumatism 2006;54(8):2368-76.
2006: Jarrod Franklin; Mark Lunt; Diane Bunn; Deborah Symmons; Alan Silman
Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis.
Annals of the rheumatic diseases 2006;65(5):617-22.
2006: Vishal R Aggarwal; John McBeth; Joanna zakrzewska; Mark Lunt; Gary Macfarlane
The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?
International journal of epidemiology 2006;35(2):468-76.
2006: Deborah Symmons; Mark Lunt; Gillian Watkins; Philip Helliwell; Sharon Jones; Neil McHugh; douglas veale
Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard".
The Journal of rheumatology 2006;33(3):552-7.
2005: Gary Macfarlane; Matthew Hotopf; Noreen Maconochie; Nick Blatchley; Alison Richards; Mark Lunt
Long-term mortality amongst Gulf War Veterans: is there a relationship with experiences during deployment and subsequent morbidity?
International journal of epidemiology 2005;34(6):1403-8.
2005: Nicola J Goodson; J Marks; Mark Lunt; Deborah Symmons
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s.
Annals of the rheumatic diseases 2005;64(11):1595-601.
2005: Dorothy J Pattison; Deborah Symmons; Mark Lunt; Ailsa Welch; Sheila A Bingham; Nicholas E Day; Alan J Silman
Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study.
The American journal of clinical nutrition 2005;82(2):451-5.
2005: Nicola J Goodson; Deborah Symmons; D G I Scott; Diane Bunn; Mark Lunt; Alan J Silman
Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Arthritis and rheumatism 2005;52(8):2293-9.
2005: Mark Lunt; Deborah Symmons; Alan J Silman
An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis: performance over five years in a primary care-based prospective study.
Arthritis and rheumatism 2005;52(8):2277-83.
2005: Mark Lunt
Prediction of ordinal outcomes when the association between predictors and outcome differs between outcome levels.
Statistics in medicine 2005;24(9):1357-69.
2005: W G Dixon; Mark Lunt; Stephen R Pye; Jonathan Reeve; Dieter Felsenberg; Alan J Silman; Terence W O'Neill
Low grip strength is associated with bone mineral density and vertebral fracture in women.
Rheumatology (Oxford, England) 2005;44(5):642-6.
2005: Vishal R Aggarwal; Mark Lunt; Joanna zakrzewska; Gary Macfarlane; Tatiana Macfarlane
Development and validation of the Manchester orofacial pain disability scale.
Community dentistry and oral epidemiology 2005;33(2):141-9.
2005: Stephen Kaptoge; LI Benevolenskaya; AK Bhalla; Jorge Cannata; S Boonen; JA Falch; Dieter Felsenberg; JD Finn; R Nuti; Krzysztof Hoszowski; Roman S Lorenc; Tomasz Miazgowski; Ivo Jajic; George P Lyritis; P Masaryk; M Naves Diaz; Gyula Poór; David M Reid; C Scheidt-Nave; JJ Stepan; Chris Todd; K Weber; A D Woolf; Dipak K Roy; Mark Lunt; Stephen R Pye; Terence W O'Neill; Alan J Silman; Jonathan Reeve
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
Bone 2005;36(3):387-98.
2005: Fraser Birrell; Mark Lunt; Gary Macfarlane; Alan Silman
Association between pain in the hip region and radiographic changes of osteoarthritis: results from a population-based study.
Rheumatology (Oxford, England) 2005;44(3):337-41.
2005: Navneet Kapur; Isabelle M Hunt; Mark Lunt; John McBeth; Francis Creed; Gary Macfarlane
Primary care consultation predictors in men and women: a cohort study.
The British journal of general practice : the journal of the Royal College of General Practitioners 2005;55(511):108-13.
2005: Fraser Birrell; Mark Lunt; Gary Macfarlane; Alan J Silman
Defining hip pain for population studies.
Annals of the rheumatic diseases 2005;64(1):95-8.
2004: Dorothy J Pattison; Deborah Symmons; Mark Lunt; Ailsa Welch; Robert Luben; Sheila A Bingham; Kay-Tee Khaw; Nicholas E Day; Alan J Silman
Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption.
Arthritis and rheumatism 2004;50(12):3804-12.
2004: Stephen Kaptoge; Gabi Armbrecht; Dieter Felsenberg; Mark Lunt; Terence W O'Neill; Alan J Silman; Jonathan Reeve
When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(12):1982-93.
2004: Roger Webb; Therese Brammah; Mark Lunt; Michelle Urwin; Tim Allison; Deborah Symmons
Opportunities for prevention of 'clinically significant' knee pain: results from a population-based cross sectional survey.
Journal of public health (Oxford, England) 2004;26(3):277-84.
2004: Terence W O'Neill; W Cockerill; Christine Matthis; Heiner Raspe; Mark Lunt; Cyrus Cooper; D Banzer; Jorge Cannata; Manuel Naves; B Felsch; Dieter Felsenberg; J Janott; O Johnell; John A Kanis; G Kragl; A Lopes Vaz; George P Lyritis; P Masaryk; Gyula Poór; David M Reid; W Reisinger; C Scheidt-Nave; JJ Stepan; Chris Todd; AD Woolf; Jonathan Reeve; Alan J Silman
Back pain, disability, and radiographic vertebral fracture in European women: a prospective study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(9):760-5.
2004: Dorothy J Pattison; Alan J Silman; Nicola J Goodson; Mark Lunt; Diane Bunn; Robert Luben; Ailsa Welch; S Bingham; Kay-Tee Khaw; Nicholas E Day; Deborah Symmons
Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study.
Annals of the rheumatic diseases 2004;63(7):843-7.
2004: Nicola J Goodson; Alan J Silman; Dorothy J Pattison; Mark Lunt; Diane Bunn; Robert Luben; Nicholas E Day; Kay-Tee Khaw; Deborah Symmons
Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis.
Rheumatology (Oxford, England) 2004;43(6):731-6.
2004: Rachelle Donn; Zaynab Alourfi; Eleftheria Zeggini; Rebecca Lamb; Francine Jury; Mark Lunt; Cristina Meazza; de benedetti fabrizio; Wendy Thomson; David Ray
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
Arthritis and rheumatism 2004;50(5):1604-10.
2004: Navneet Kapur; Isabelle M Hunt; Mark Lunt; John McBeth; Francis Creed; Gary Macfarlane
Psychosocial and illness related predictors of consultation rates in primary care--a cohort study.
Psychological medicine 2004;34(4):719-28.
2004: Anne Barton; Hazel Platt; Fiona Salway; Deborah Symmons; Mark Lunt; Jane Worthington; Alan Silman
Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis.
The Journal of rheumatology 2004;31(3):442-7.
2004: Anne Barton; H Platt; Fiona Salway; Deborah Symmons; E Barrett; Marwan Bukhari; Mark Lunt; Eleftheria Zeggini; Stephen Eyre; Anne Hinks; DJ Tellam; B Brintnell; W E R Ollier; Jane Worthington; Alan Silman
Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis.
Annals of the rheumatic diseases 2004;63(3):280-4.
2004: W Cockerill; Mark Lunt; Alan J Silman; Cyrus Cooper; P Lips; AK Bhalla; Jorge Cannata; R Eastell; Dieter Felsenberg; C Gennari; O Johnell; John A Kanis; C Kiss; P Masaryk; Manuel Naves; Gyula Poór; Heiner Raspe; David M Reid; Jonathan Reeve; JJ Stepan; C Todd; AD Woolf; Terence W O'Neill
Health-related quality of life and radiographic vertebral fracture.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(2):113-9.
2003: Gary Macfarlane; Anne-Marie Biggs; Noreen Maconochie; Matthew Hotopf; Pat Doyle; Mark Lunt
Incidence of cancer among UK Gulf war veterans: cohort study.
BMJ (Clinical research ed.) 2003;327(7428):1373.
2003: Mark Lunt; Terence W O'Neill; Dieter Felsenberg; Jonathan Reeve; John A Kanis; Cyrus Cooper; Alan J Silman
Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS).
Bone 2003;33(4):505-13.
2003: Elizabeth S Nahit; Isabelle M Hunt; Mark Lunt; G Dunn; Alan J Silman; Gary Macfarlane
Effects of psychosocial and individual psychological factors on the onset of musculoskeletal pain: common and site-specific effects.
Annals of the rheumatic diseases 2003;62(8):755-60.
2003: Alexandra Tomkinson; Jane H Gibson; Mark Lunt; Mark Harries; Jonathan Reeve
Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runners.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2003;14(6):462-8.
2003: Roger Webb; Therese Brammah; Mark Lunt; Michelle Urwin; Tim Allison; Deborah Symmons
Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population.
Spine 2003;28(11):1195-202.
2003: de benedetti fabrizio; Cristina Meazza; Marina Vivarelli; Federica Rossi; Angela Pistorio; Rebecca Lamb; Mark Lunt; Wendy Thomson; Angelo Ravelli; Rachelle Donn; Alberto Martini
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
Arthritis and rheumatism 2003;48(5):1398-407.
2003: C Morgan; C Knight; Mark Lunt; C M Black; Alan J Silman
Predictors of end stage lung disease in a cohort of patients with scleroderma.
Annals of the rheumatic diseases 2003;62(2):146-50.
2003: Fraser Birrell; Cara Afzal; Elizabeth S Nahit; Mark Lunt; Gary Macfarlane; Cyrus Cooper; Peter R Croft; Gillian Hosie; Alan J Silman
Predictors of hip joint replacement in new attenders in primary care with hip pain.
The British journal of general practice : the journal of the Royal College of General Practitioners 2003;53(486):26-30.
2003: Marwan Bukhari; Nicola J Wiles; Mark Lunt; BJ Harrison; D G I Scott; Deborah Symmons; Alan J Silman
Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study.
Arthritis and rheumatism 2003;48(1):46-53.
2003: C Morgan; Mark Lunt; H Brightwell; P Bradburn; W Fallow; M Lay; Alan Silman; Ian N Bruce
Contribution of patient related differences to multidrug resistance in rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(1):15-9.
2002: Mark Lunt; AA Ismail; Dieter Felsenberg; Cyrus Cooper; John A Kanis; Jonathan Reeve; Alan J Silman; Terence W O'Neill
Defining incident vertebral deformities in population studies: a comparison of morphometric criteria.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2002;13(10):809-15.
2002: Rachelle Donn; Zaynab Alourfi; de benedetti fabrizio; Cristina Meazza; Eleftheria Zeggini; Mark Lunt; Adam Stevens; Emma Shelley; Rebecca Lamb; W E R Ollier; Wendy Thomson; David Ray
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
Arthritis and rheumatism 2002;46(9):2402-9.
2002: G Holt; Kay-Tee Khaw; David M Reid; Juliet E Compston; A Bhalla; A D Woolf; NJ Crabtree; Nichola Dalzell; Bridget Wardley-Smith; Mark Lunt; Jonathan Reeve
Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometry.
The British journal of radiology 2002;75(897):736-42.
2002: Nicola J Goodson; Nicola J Wiles; Mark Lunt; Elizabeth M Barrett; Alan J Silman; Deborah Symmons
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.
Arthritis and rheumatism 2002;46(8):2010-9.
2002: Deborah Symmons; G Turner; R Webb; P Asten; E Barrett; Mark Lunt; D Scott; Alan Silman
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century.
Rheumatology (Oxford, England) 2002;41(7):793-800.
2002: Marwan Bukhari; Mark Lunt; BJ Harrison; D G I Scott; Deborah Symmons; Alan J Silman
Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort.
Arthritis and rheumatism 2002;46(4):906-12.
2002: Marwan Bukhari; Mark Lunt; BJ Harrison; D G I Scott; Deborah Symmons; Alan J Silman
Erosions in inflammatory polyarthritis are symmetrical regardless of rheumatoid factor status: results from a primary care-based inception cohort of patients.
Rheumatology (Oxford, England) 2002;41(3):246-52.
2002: NJ Crabtree; H Kroger; A Martin; Huibert A P Pols; Roman S Lorenc; J Nijs; JJ Stepan; JA Falch; Tomasz Miazgowski; Simeon Grazio; P Raptou; J Adams; A Collings; Kay-Tee Khaw; Neil Rushton; Mark Lunt; A K Dixon; Jonathan Reeve
Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2002;13(1):48-54.
2001: Marwan Bukhari; B Harrison; Mark Lunt; D G I Scott; Deborah Symmons; Alan J Silman
Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study.
Arthritis and rheumatism 2001;44(6):1248-53.
2001: Nicola J Wiles; Mark Lunt; Elizabeth M Barrett; Marwan Bukhari; Alan J Silman; Deborah Symmons; Graham Dunn
Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity.
Arthritis and rheumatism 2001;44(5):1033-42.
2001: Mark Lunt; Wolfgang Gowin; Gabi Armbrecht; Dieter Felsenberg
A statistical method to minimize magnification errors in serial vertebral radiographs.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(11):909-13.
2001: Mark Lunt; P Masaryk; C Scheidt-Nave; J Nijs; Gyula Poór; Huibert A P Pols; JA Falch; G Hammermeister; David M Reid; LI Benevolenskaya; K Weber; Jorge Cannata; Terence W O'Neill; Dieter Felsenberg; Alan J Silman; Jonathan Reeve
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(8):688-98.
2001: Terence W O'Neill; Cyrus Cooper; JD Finn; Mark Lunt; D Purdie; David M Reid; R Rowe; AD Woolf; W A Wallace
Incidence of distal forearm fracture in British men and women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(7):555-8.
2000: NJ Crabtree; Mark Lunt; G Holt; H Kröger; H Burger; Simeon Grazio; Kay-Tee Khaw; Roman S Lorenc; J Nijs; JJ Stepan; JA Falch; Tomasz Miazgowski; P Raptou; Huibert A P Pols; J Dequeker; S Havelka; Krzysztof Hoszowski; Ivo Jajic; S Czekalski; George P Lyritis; Alan J Silman; Jonathan Reeve
Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study.
Bone 2000;27(1):151-9.
2000: NJ Crabtree; J Wright; A Walgrove; J Rea; L Hanratty; Mark Lunt; I Fogelman; R Palmer; Margaret Rose Vickers; Juliet E Compston; J Reev
Vertebral morphometry: repeat scan precision using the Lunar Expert-XL and the Hologic 4500A. A study for the 'WISDOM' RCT of hormone replacement therapy.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(6):537-43.
1999: K Weber; Mark Lunt; Wolfgang Gowin; T Lauermann; Gabi Armbrecht; E Wieland; Georg Leb; T O'Neill; Dieter Felsenberg; Jonathan Reeve
Measurement imprecision in vertebral morphometry of spinal radiographs obtained in the European Prospective Osteoporosis Study: consequences for the identification of prevalent and incident deformities.
The British journal of radiology 1999;72(862):957-66.
1999: V Scoutellas; Terence W O'Neill; Mark Lunt; Jonathan Reeve; Alan J Silman
Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.
Maturitas 1999;32(3):179-87.
1999: Jonathan Reeve; J Walton; L J Russell; Mark Lunt; R Wolman; R Abraham; J Justice; A Nicholls; Bridget Wardley-Smith; J R Green; Angela Mitchell
Determinants of the first decade of bone loss after menopause at spine, hip and radius.
QJM : monthly journal of the Association of Physicians 1999;92(5):261-73.
1999: KL Bell; Nigel Loveridge; Jon Power; Nigel J Garrahan; M Stanton; Mark Lunt; B F Meggitt; Jonathan Reeve
Structure of the femoral neck in hip fracture: cortical bone loss in the inferoanterior to superoposterior axis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(1):111-9.
1997: Mark Lunt; Dieter Felsenberg; Jonathan Reeve; LI Benevolenskaya; Jorge Cannata; J Dequeker; C Dodenhof; JA Falch; P Masaryk; Huibert A P Pols; Gyula Poór; David M Reid; C Scheidt-Nave; K Weber; J Varlow; John A Kanis; Terence W O'Neill; Alan J Silman
Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(11):1883-94.
1997: KL Bell; Nigel Loveridge; P C Lindsay; Mark Lunt; Nigel J Garrahan; Juliet E Compston; Jonathan Reeve
Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(8):1231-40.
1997: Mark Lunt; Dieter Felsenberg; J Adams; LI Benevolenskaya; Jorge Cannata; J Dequeker; C Dodenhof; JA Falch; O Johnell; Kay-Tee Khaw; P Masaryk; Huibert A P Pols; Gyula Poór; D Reid; C Scheidt-Nave; K Weber; Alan J Silman; Jonathan Reeve
Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(3):175-89.
1996: Jonathan Reeve; H Kröger; J Nijs; J Pearson; Dieter Felsenberg; Christoph Reiners; P Schneider; A Mitchell; P Ruegsegger; C Zander; M Fischer; J Bright; M Henley; Mark Lunt; J Dequeker
Radial cortical and trabecular bone densities of men and women standardized with the European Forearm Phantom.
Calcified tissue international 1996;58(3):135-43.
1996: Jonathan Reeve; Mark Lunt; W Kalender; J Dequeker; I Jajic; R Lorenc; H Pols; Gyula Poór; J Stepan
The European spine phantom: reply to Dr Peter Tothill's letter.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1996;6(2):183-4.
1995: J Pearson; J Dequeker; Jonathan Reeve; Dieter Felsenberg; M Henley; J Bright; Mark Lunt; J Adams; M Diaz Curiel; F Galan
Dual X-ray absorptiometry of the proximal femur: normal European values standardized with the European Spine Phantom.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(2):315-24.